UBS Knock-Out AZN/ DE000UM5WDX8 /
| 2024-11-07 9:36:08 AM | Chg.-0.240 | Bid9:56:51 PM | Ask9:56:51 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.780EUR | -23.53% | - Bid Size: - |
- Ask Size: - |
AstraZeneca PLC | 56.1473 - | 2078-12-31 | Call |
Master data
| Issuer: | UBS AG, LONDON BRANCH |
|---|---|
| WKN: | UM5WDX |
| Currency: | EUR |
| Underlying: | AstraZeneca PLC |
| Type: | Knock-out |
| Option type: | Call |
| Strike price: | 56.1473 - |
| Maturity: | Endless |
| Issue date: | 2024-05-14 |
| Last trading day: | 2078-12-31 |
| Ratio: | 10:1 |
| Exercise type: | Bermuda |
| Quanto: | No |
| Gearing: | 7.73 |
| Knock-out: | 56.1473 |
| Knock-out violated on: | - |
| Distance to knock-out: | 3.3954 |
| Distance to knock-out %: | 5.70% |
| Distance to strike price: | 3.3954 |
| Distance to strike price %: | 5.70% |
Calculated values
| Fair value: | - |
|---|---|
| Implied volatility: | - |
| Historic volatility: | - |
| Parity: | - |
| Time value: | - |
| Break-even: | - |
| Moneyness: | - |
| Premium: | 0.07 |
| Premium p.a.: | 0.00 |
| Spread abs.: | 0.01 |
| Spread %: | 1.32% |
| Delta: | - |
| Theta: | - |
| Omega: | - |
| Rho: | - |
Quote data
| Open: | 0.780 |
|---|---|
| High: | 0.780 |
| Low: | 0.000 |
| Market phase: | CL |
All quotes in EUR
Performance
| 1 Week | -52.44% | ||
|---|---|---|---|
| 1 Month | -61.95% | ||
| 3 Months | -67.50% | ||
| YTD | - | ||
| 1 Year | - | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - |
| 1W High / 1W Low: | 1.640 | 1.020 |
|---|---|---|
| 1M High / 1M Low: | 2.140 | 1.020 |
| 6M High / 6M Low: | - | - |
| High (YTD): | - | - |
| Low (YTD): | - | - |
| 52W High: | - | - |
| 52W Low: | - | - |
| Avg. price 1W: | 1.432 | |
| Avg. volume 1W: | 0.000 | |
| Avg. price 1M: | 1.877 | |
| Avg. volume 1M: | 0.000 | |
| Avg. price 6M: | - | |
| Avg. volume 6M: | - | |
| Avg. price 1Y: | - | |
| Avg. volume 1Y: | - | |
| Volatility 1M: | 115.80% | |
| Volatility 6M: | - | |
| Volatility 1Y: | - | |
| Volatility 3Y: | - |
